Trapp B D, Bö L, Mörk S, Chang A
Department of Neurosciences, Lerner Research Institute, The Cleveland Clinic Foundation, OH 44195, USA.
J Neuroimmunol. 1999 Jul 1;98(1):49-56. doi: 10.1016/s0165-5728(99)00081-8.
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system. The primary pathological target in multiple sclerosis is myelin. Most MS patients follow a relapsing-remitting (RR-MS) course for 10 to 15 years that transforms into a chronic or secondary progressive disease (SP-MS). This review summarizes studies from our laboratory that implicate activated microglia and astrocytes in early stages of myelin destruction in MS brain. In addition, we review evidence that indicates that axonal transection is a major pathological process in multiple sclerosis. Our data support the hypothesis that neurological disability in RR-MS is due to inflammatory demyelination while axonal loss plays a significant role in the irreversible neurological decline in SP-MS. Further elucidation of the pathological targets and pathological mechanisms of tissue destruction in MS brain will help identify new therapeutics.
多发性硬化症(MS)是一种中枢神经系统的炎症性疾病。多发性硬化症的主要病理靶点是髓鞘。大多数MS患者会经历10至15年的复发缓解型(RR-MS)病程,之后转变为慢性或继发进展性疾病(SP-MS)。本综述总结了我们实验室的研究,这些研究表明活化的小胶质细胞和星形胶质细胞参与了MS脑髓鞘破坏的早期阶段。此外,我们还综述了表明轴突横断是多发性硬化症主要病理过程的证据。我们的数据支持这样一种假说,即RR-MS中的神经功能障碍是由于炎症性脱髓鞘,而轴突丢失在SP-MS不可逆的神经功能衰退中起重要作用。进一步阐明MS脑内组织破坏的病理靶点和病理机制将有助于确定新的治疗方法。